RA
Ranjita Abhay Bhattacharya
About Ranjita Abhay Bhattacharya
Data last updated:
Ranjita Abhay Bhattacharya is a Director at Aurinko Onehealth Private Limited (since 2014), Designated Partner at Evig Biopharma Llp (since 2016) and Designated Partner at Terrabloom Biotech Llp (since 2025). The companies operate in Healthcare and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹11.40 Cr; the largest is Aurinko Onehealth Private Limited at ₹10.84 Cr (FY 2025). Earlier, Ranjita Abhay Bhattacharya was a Director at Vet Stemcell Innovations Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Nov 2014 | 2014 | ₹10.84 Cr (FY 2025) | Active | |
| Designated Partner | 29 Feb 2016 | 2016 | ₹56.3 Lakh (FY 2022) | Active | |
| Designated Partner | 04 Jul 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Dec 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ranjita Abhay Bhattacharya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaykumar Bhattacharya | 06985388 | Aurinko Onehealth Private Limited , Evig Biopharma Llp and 1 more | Director |
| Shashwat Bhattacharya | 10229698 | Aurinko Onehealth Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranjita Abhay Bhattacharya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranjita Abhay Bhattacharya
Ranjita Abhay Bhattacharya currently holds 3 directorships: Aurinko Onehealth Private Limited (Director, since 21 Nov 2014, revenue ₹10.84 Cr (FY 2025)); Evig Biopharma Llp (Designated Partner, since 29 Feb 2016, revenue ₹56.3 Lakh (FY 2022)); Terrabloom Biotech Llp (Designated Partner, since 04 Jul 2025).
Ranjita Abhay Bhattacharya was first appointed on 21 Nov 2014 as Director at Aurinko Onehealth Private Limited. The most recent appointment on record is 04 Jul 2025 at Terrabloom Biotech Llp.
The 2 current companies of Ranjita Abhay Bhattacharya that report revenue have a combined latest revenue of ₹11.40 Cr: Aurinko Onehealth Private Limited ₹10.84 Cr (FY 2025); Evig Biopharma Llp ₹56.3 Lakh (FY 2022).
Ranjita Abhay Bhattacharya held 1 earlier board appointment: Vet Stemcell Innovations Private Limited (Director, from 05 Dec 2014).
The current boards of Ranjita Abhay Bhattacharya's companies include Abhaykumar Bhattacharya (Aurinko Onehealth Private Limited), Shashwat Bhattacharya (Aurinko Onehealth Private Limited).